HCA
VNDA icon

Harbor Capital Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Harbor Capital Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$359K Buy
+51,976
New +$401K 0.03% 539

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Harbor Capital Advisors's VNDA Position: Q1 2026 in Review

Harbor Capital Advisors opened a new position in Vanda Pharmaceuticals (VNDA) in Q1 2026: 51,976 shares worth $359K. The stake represents 0.03% of the portfolio and ranks #539 among its holdings.

170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Harbor Capital Advisors held 51,976 shares of Vanda Pharmaceuticals worth $359K as of Q1 2026.
  • Vanda Pharmaceuticals was a new Harbor Capital Advisors position in Q1 2026.
  • Vanda Pharmaceuticals made up 0.03% of Harbor Capital Advisors's portfolio in Q1 2026, its #539 holding.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.